Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS9950 tablets in virologically suppressed chronic hepatitis B
CTR20231755Phase 2Completed
- Sponsor
- Chengdu Shengdi
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS9950 in Chronic Hepatitis B (CHB), sponsored by Chengdu Shengdi. Started Jun 2023; status: completed.
02
Drugs
HRS9950
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20231755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231755.